Trial Profile
Safety and Efficacy of Combination Acthar Gel and Tacrolimus in the Treatment of Steroid Resistant Nephrotic Syndrome
Status:
Suspended
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary) ; Tacrolimus (Primary)
- Indications Nephrotic syndrome
- Focus Therapeutic Use
- 15 Feb 2021 Planned End Date changed from 1 Dec 2017 to 1 Dec 2021.
- 15 Feb 2021 Status changed from active, no longer recruiting to suspended.
- 08 Feb 2017 New trial record